Cmed, Inc.

Calculating rank

USPTO Granted Patents = 4

Trademarks = 2

Forward Citations = 558

Loading Chart...

3 inventors (with patents filed for the assignee):

Gregory R Holland (3 out of 13 patents)

Michael R Swenson (3 out of 4 patents)

Glenn F Spaulding (1 out of 12 patents)

4 patents: Sort by Forward Citations

1. 6001643 - Controlled hydrodynamic cell culture environment for three dimensional (1999-12-14),

2. 5961448 - Virtual medical instrument for performing medical diagnostic testing on (1999-10-05),

3. 5776057 - Virtual medical instrument for performing medical diagnostic testing on (1998-07-07),

4. 5623925 - Virtual medical instrument for performing medical diagnostic testing on (1997-04-29),

Company Overview

Cmed is a global technology-led oncology CRO specialized in delivering innovative solutions to biopharmaceutical companies. Their experience allows them to simplify complex processes, reduce costs, and speed up medical developments. They offer a range of services such as clinical trial management, data management, and clinical analytics to support the entire drug development process.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#529 in Irvine, CA

#14,063 in California

#60,704 in US

Irvine, CA, United States of America

Cmed, Inc.

Forward Citations = 558

3 inventors:

Gregory R Holland (3 out of 13 patents)

Michael R Swenson (3 out of 4 patents)

Glenn F Spaulding (1 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cmed, Inc.. Retrieved from https://idiyas.com/company/cmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]